Mathematical models for a new era of malaria eradication

PLoS Medicine

Volumn 5, Issue 11, 2008, Pages 1542-1543

  Boni, Maciej F ^a,b   Buckee, Caroline O ^c   White, Nicholas J ^d,e  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b Medical Research Council Centre for Genomics and Global Health   (United Kingdom)

^c Wellcome Trust/KEMRI Collaborative Programme   (Kenya)

^d MAHIDOL UNIVERSITY   (Thailand)

^e CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

8 AMINOQUINOLINE DERIVATIVE; ANTIMALARIAL AGENT; ARTEMISININ;

DISEASE TRANSMISSION; DRUG BIOAVAILABILITY; HEALTH SURVEY; INCIDENCE; MALARIA; MALARIA CONTROL; MATHEMATICAL MODEL; PARASITE TRANSMISSION; PREVALENCE; PROPHYLAXIS; PUBLIC HEALTH; SHORT SURVEY; TANZANIA; ARTICLE; HUMAN; INFECTION CONTROL; MALARIA FALCIPARUM; MOSQUITO; PARASITOLOGY; THEORETICAL MODEL;

ANTIMALARIALS; COMMUNICABLE DISEASE CONTROL; HUMANS; MALARIA, FALCIPARUM; MODELS, THEORETICAL; MOSQUITO CONTROL;

EID: 56749154050     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0050231     Document Type: Short Survey

References (15)

1. Bloom BR (2007) Sustainable health: A new dimension of sustainability science. Proc Natl Acad Sci U S A 104: 15969.
2. McKenzie FE (2000) Why model malaria? Parasitol Today 16: 511-516.
3. Dye C, Hasibeder G (1986) Population dynamics of mosquito-borne disease: Effects of flies which bite some people more frequently than others. Trans R Soc Trop Med Hyg 80: 69-77.
4. Curtis CF, Otoo LN (1986) A simple model of the build-up of resistance to mixtures of anti-malarial drugs. Trans R Soc Trop Med Hyg 80: 889-892.
5. White NJ, Olliaro PL (1996) Rationale for combination therapy for malaria. Parasitol Today 12: 399-401.
6. Smith T, Maire N, Ross A, Penny M, Chitnis N, et al. (2008) Towards a comprehensive simulation model of malaria epidemiology and control. Parasitology. E-pub 11 August 2008. doi:10.1017/S0031182008000371
7. Okell LC, Drakeley CJ, Bousema T, Whitty CJM, Ghani AC (2008) Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity. PLoS Med 5: e226. doi:10.1371/journal.pmed. 0050226
8. Bhattarai A, Ali AS, Kachur SP, Mårtensson A, Abbas AK, et al. (2007) Impact of artemisininbased combination therapy and insecticidetreated nets on malaria burden in Zanzibar. PLoS Med 4: e309. doi:10.1371/journal.pmed. 0040309
9. Clinton Foundation (2008) Tanzania Pilot ACT Subsidy: Report on Findings. Available: http://www.clintonfoundation.org/download/?guid=a14a4fca-98de-102b- be34-001143e0d9b6. Accessed 20 October 2008.
10. Hastings IM, Watkins WM (2004) Tolerance is the key to understanding antimalarial drug resistance. Trends Parasitol 22: 71-77
11. Prudhomme O'Meara W, Smith DL, McKenzie FE (2006) Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria. PLoS Med 3: e141. doi:10.1371/journal.pmed.0030141
12. Barnes KI, Watkins WM, White NJ (2008) Antimalarial dosing regimens and drug resistance. Trends Parasitol 24: 127-134.
13. Boni MF, Smith DL, Laxminarayan R (2008) Benefits of using multiple first-line therapies against malaria. Proc Natl Acad Sci U S A 105: 14216-14221.
14. White NJ (2008) Qinghaosu (artemisinin): The price of success. Science 320: 330-334.
15. World Health Organization (2008) World Malaria Report. Available: http://www.who.int/malaria/me_reports.html. Accessed 20 October 2008.